Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MSGS
MSGS logo

MSGS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Madison Square Garden Sports Corp (MSGS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
344.120
1 Day change
4.24%
52 Week Range
348.200
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Madison Square Garden Sports Corp (MSGS) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are potential catalysts such as the possible separation of the Knicks and Rangers and increasing sports team valuations, the company's financial performance is weak, and technical indicators do not show a clear bullish trend. Analysts' ratings are mixed, with some downgrades due to valuation concerns. Additionally, there are no strong trading signals from Intellectia Proprietary Trading Signals, and options data suggests a neutral to slightly bearish sentiment.

Technical Analysis

The stock's MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 49.779, and while moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the stock is trading below the pivot level of 333.399, with key support at 323.948 and resistance at 342.849. Overall, the technical indicators do not provide a strong buy signal.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The open interest put-call ratio of 0.67 and option volume put-call ratio of 0.78 suggest a neutral to slightly bearish sentiment in the options market.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
12

Positive Catalysts

  • Potential separation of the Knicks and Rangers into standalone companies, which could unlock value.

  • Increasing valuations of sports teams, as highlighted by the recent Padres sale.

  • Analysts like Guggenheim and JPMorgan see long-term value in the stock, with price targets as high as $401 and $400, respectively.

Neutral/Negative Catalysts

  • Weak financial performance in Q1 2026, with a 25.99% YoY revenue drop and declining gross margin.

  • Citi downgraded the stock to Neutral due to valuation concerns.

  • Mixed analyst ratings and no recent congress trading data to support institutional confidence.

Financial Performance

In Q1 2026, the company reported a 25.99% YoY revenue decline to $39.45 million. Net income improved slightly but remains negative at -$8.81 million. EPS increased to -0.37, up 19.35% YoY, while gross margin dropped to 80.28%, down 6.20% YoY. Overall, the financials indicate weak growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed on MSGS. Guggenheim and JPMorgan maintain Buy/Overweight ratings with high price targets of $401 and $400, citing potential catalysts like the Knicks and Rangers separation. However, Citi downgraded the stock to Neutral, citing valuation concerns after the recent rally. Seaport Research and Susquehanna remain positive but highlight risks tied to tax laws and playoff performance.

Wall Street analysts forecast MSGS stock price to fall
5 Analyst Rating
Wall Street analysts forecast MSGS stock price to fall
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 330.130
sliders
Low
220
Averages
250
High
290
Current: 330.130
sliders
Low
220
Averages
250
High
290
Citi
Jason Bazinet
Buy
to
Neutral
downgrade
$337 -> $355
AI Analysis
2026-04-23
Reason
Citi
Jason Bazinet
Price Target
$337 -> $355
AI Analysis
2026-04-23
downgrade
Buy
to
Neutral
Reason
Citi analyst Jason Bazinet downgraded MSG Sports to Neutral from Buy with a price target of $355, up from $337. The firm cites valuation for the downgrade following the stock's recent rally. Citi no longer views MSG Sports' risk/reward as attractive.
Guggenheim
Buy
maintain
$355 -> $401
2026-04-21
Reason
Guggenheim
Price Target
$355 -> $401
2026-04-21
maintain
Buy
Reason
Guggenheim raised the firm's price target on MSG Sports to $401 from $355 and keeps a Buy rating on the shares. The firm, which updated its model to reflect six home Knicks playoff games, sees a number of catalysts to unlock value, including separating the Knicks and the Rangers, NBA expansion in Las Vegas and Seattle and the NBA European expansion.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MSGS
Unlock Now

People Also Watch